Epigenetic Underpinnings of Tumor-Immune Dynamics in Prostate Cancer Immune Suppression

De novo post-translational acetylation of the AR, HOXB13, and H2A at K609, K13, and K130, respectively, and phosphorylation of H4 at Y88 have emerged as key epigenetic modifications associated with castration-resistant prostate cancer.